Clear Search sequence regions


  • adult (2)
  • effects treatment (1)
  • graft (8)
  • heart (1)
  • heart transplant (3)
  • humans (1)
  • patients (3)
  • races (1)
  • registry (1)
  • transplant (5)
  • Sizes of these terms reflect their relevance to your search.

    Black heart transplant recipients are more likely to receive induction immunosuppression compared to other races because of higher rates of acute rejection, graft failure, and mortality. However, it is not known whether contemporary induction immunosuppression improves their post-transplant outcomes. To evaluate whether Black patients who were prescribed induction immunosuppression therapy have lower all-cause mortality or graft-failure rates compared to those who were not, we studied Black U.S. adult heart transplant recipients in the Scientific Registry of Transplant Recipients database (2008-2018). We used multivariable Cox proportional hazards regression analysis to compare the hazards of all-cause mortality or graft failure as a composite, for patients who were prescribed induction immunosuppression and those who were not. Among 5160 recipients, 2787 (54.0%) were prescribed induction immunosuppression and 2373 (46.0%) were not. There was no evidence of survival differences according to induction immunosuppression for the composite of all-cause mortality or graft failure (aHR = 1.13, 95% CI 0.96-1.32), mortality (aHR = 1.14, 95% CI 0.97-1.34), graft failure (aHR = 1.05, 95% CI 0.82-1.34) and acute rejection (aHR = 1.00, 95% CI 0.89-1.12). Given the side effects of treatment, future guidelines should reconsider the recommendation for induction immunosuppression among Black patients. © 2022 The American Society of Transplantation and the American Society of Transplant Surgeons.

    Citation

    Soziema Salia, Elizabeth Mostofsky, Suruchi Gupta, Laura Lehman, Francisco J Barrera, Lathan Liou, Shweta R Motiwala, Murray A Mittleman. Post-transplant mortality and graft failure after induction immunosuppression among Black heart transplant recipients in the United States. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2022 Nov;22(11):2586-2597

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35758522

    View Full Text